Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Cash Interest Paid
Glenmark Life Sciences Ltd
Cash Interest Paid Peer Comparison
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Cash Interest Paid
₹15.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash Interest Paid
₹2.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Cash Interest Paid
₹648.3m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash Interest Paid
₹2.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash Interest Paid
₹3.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Glenmark Life Sciences Ltd's Cash Interest Paid?
Cash Interest Paid
15.5m
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Cash Interest Paid amounts to 15.5m INR.
What is Glenmark Life Sciences Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 1Y
4 731%
Over the last year, the Cash Interest Paid growth was 4 731%.